Table 3 Results and performances of the multivariable modeling involving the deep learning risk scores and the FNCLCC grade.

From: Prognostic prediction in soft-tissue sarcomas using deep learning and digital pathology of tumor and margin areas

 

Predictors

HR

P value

c-index in Training

c-index in Validation-1

c-index in Validation-2

DL-C model

   
 

Size (mm)

1.01 (1.01–1.02)

< 0.0001***

0.793 (0.732–0.854)

0.759 (0.643–0.876)

0.741 (0.662–0.821)

Histologic type (ref: M/RC-LPS)

  
 

Leiomyosarcoma

1.66 (0.42–6.59)

0.4679

 

Liposarcoma

0.26 (0.06–1.15)

0.0760

 

Myxofibrosarcoma

0.56 (0.13–2.35)

0.4298

 

Other

1.41 (0.39–5.11)

0.5987

 

Undifferentiated sarcoma

0.54 (0.15–1.98)

0.3547

DL-C High risk

3.28 (1.56–6.89)

0.0018**

Age (years)

1.03 (1–1.05)

0.0416*

Chemotherapy (yes)

0.63 (0.24–1.67)

0.3583

Radiotherapy (yes)

0.57 (0.28–1.16)

0.1201

DL-P model

   
 

Size (mm)

1.02 (1.01–1.02)

 < 0.0001***

0.851 (0.803–0.900)

0.74 (0.635–0.845)

0.667 (0.573–0.760)

Histologic type (ref: M/RC-LPS)

  
 

Leiomyosarcoma

0.43 (0.09–2.05)

0.2926

 

Liposarcoma

0.1 (0.02–0.5)

0.0051*

 

Myxofibrosarcoma

0.16 (0.03–0.8)

0.0253*

 

Other

0.52 (0.13–2.2)

0.3769

 

Undifferentiated sarcoma

0.12 (0.03–0.54)

0.0054*

DL-P High risk

23.41 (6.98–78.5)

 < 0.0001***

Age (years)

1.01 (0.99–1.04)

0.2782

Chemotherapy (yes)

0.62 (0.23–1.67)

0.3451

Radiotherapy (yes)

0.52 (0.26–1.04)

0.0658

DL-R model

   
 

Size (mm)

1.01 (1.01–1.02)

< 0.0001***

0.790 (0.733–0.847)

0.690 (0.564–0.817)

0.664 (0.567–0.760)

Histologic type (ref: M/RC-LPS)

  
 

Leiomyosarcoma

2.6 (0.67–10.03)

0.1656

 

Liposarcoma

0.46 (0.12–1.83)

0.2695

 

Myxofibrosarcoma

1.19 (0.31–4.53)

0.8036

 

Other

1.95 (0.56–6.81)

0.2958

 

Undifferentiated sarcoma

0.92 (0.27–3.12)

0.8904

DL-R (binary)

3.74 (1.76–7.96)

0.0006***

Age (years)

1.02 (1–1.04)

0.1094

Chemotherapy (yes)

1.01 (0.39–2.63)

0.9865

Radiotherapy (yes)

0.46 (0.22–0.95)

0.0347*

DL-CP model

   
 

Size (mm)

1.01 (1.01–1.02)

 < 0.0001***

0.819 (0.761–0.877)

0.74 (0.623–0.856)

0.698 (0.604–0.791)

Histologic type (ref: M/RC-LPS)

  
 

Leiomyosarcoma

0.57 (0.13–2.51)

0.4605

 

Liposarcoma

0.22 (0.05–0.97)

0.0458*

 

Myxofibrosarcoma

0.26 (0.06–1.17)

0.0793

 

Other

0.87 (0.23–3.26)

0.8379

 

Undifferentiated sarcoma

0.22 (0.06–0.89)

0.0342*

DL-CP High risk

8.82 (3.39–22.96)

 < 0.0001***

Age (years)

1.03 (1.01–1.06)

0.0068*

Chemotherapy (yes)

0.68 (0.25–1.8)

0.4324

Radiotherapy (yes)

0.79 (0.38–1.64)

0.5224

DL-CPR model

   
 

Size (mm)

1.01 (1.01–1.02)

< 0.0001***

0.804 (0.738–0.870)

0.786 (0.689–0.883)

0.698 (0.620–0.775)

Histologic type (ref: M/RC-LPS)

  
 

Leiomyosarcoma

1.76 (0.46–6.67)

0.4082

 

Liposarcoma

0.55 (0.14–2.16)

0.3927

 

Myxofibrosarcoma

0.69 (0.18–2.61)

0.5808

 

Other

1.99 (0.56–7.06)

0.2860

 

Undifferentiated sarcoma

0.58 (0.17–1.96)

0.3809

DL-CPR High risk

6.86 (2.91–16.18)

 < 0.0001***

Age (years)

1.02 (1–1.05)

0.0693

Chemotherapy (yes)

0.79 (0.3–2.06)

0.6271

Radiotherapy (yes)

0.54 (0.27–1.07)

0.0758

Grade-based model

   
 

Size (mm)

1.01 (1.01–1.02)

< 0.0001***

0.764 (0.699–0.828)

0.739 (0.621–0.856)

0.723 (0.652–0.794)

Histologic type (ref: M/RC-LPS)

  
 

Leiomyosarcoma

2.61 (0.71–9.65)

0.1493

 

Liposarcoma

0.4 (0.1–1.69)

0.2136

 

Myxofibrosarcoma

1.09 (0.28–4.28)

0.8981

 

Other

2.21 (0.66–7.44)

0.2002

 

Undifferentiated sarcoma

0.86 (0.25–2.96)

0.8093

FNCLCC Grade (ref: grade I)

1.87 (0.59–5.96)

0.2908

Age (years)

1.02 (1–1.05)

0.0444*

Chemotherapy (yes)

0.71 (0.27–1.81)

0.4697

Radiotherapy (yes)

0.61 (0.3–1.23)

0.1689

  1. c-index concordance index, DL deep learning risk score (based on C: tumor centrum, P: tumor periphery and R: tumor surrounding tissues, and their combination), HR hazard ratio, M/RC-LPS myxoid/round cells liposarcoma, ref reference.
  2. Hazard ratio and c-index are given with 95% confidence intervals.
  3. *: P < 0.05, **: P < 0.005, ***: P < 0.001. Significant results are in bold.